Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

Omeros Corp.

GridBrain

GridBrain Sign in

GridSentinel

GridSentinel Sign in

GridAegis

GridAegis Sign in

Key Metrics

Market Snapshot

About

Omeros Corporation is a biopharmaceutical company focused on therapies targeting complement-mediated diseases and central nervous system disorders. The company's products and pipeline include treatments for surgical bleeding, renal disease, and neurological conditions. Omeros markets Omidria, an ophthalmic drug used during cataract surgery.